{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:22:07Z","timestamp":1791685327767,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016198","name":"Idorsia Pharmaceuticals Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omta.2025.201658","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T16:08:21Z","timestamp":1766765301000},"page":"201658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sinbaglustat is efficacious in GM2 gangliosidosis primarily through inhibition of GBA2 rather than GCS"],"prefix":"10.1016","volume":"34","author":[{"given":"Michel A.","family":"Steiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Vaillant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Garzotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gulinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa L.","family":"VanBrakle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Ryge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"M\u00fchlemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostantin","family":"Dobrenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W.D.","family":"Welford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omta.2025.201658_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/ml100192b","article-title":"Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugars","volume":"2","author":"Ghisaidoobe","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.omta.2025.201658_bib2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/cts.12911","article-title":"Assessment of Target Engagement in a First-in-Human Trial with Sinbaglustat, an Iminosugar to Treat Lysosomal Storage Disorders","volume":"14","author":"Gehin","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.omta.2025.201658_bib3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3390\/ijms18020441","article-title":"A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omta.2025.201658_bib4","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ymthe.2019.05.018","article-title":"Substrate Reduction Therapy for Sandhoff Disease through Inhibition of Glucosylceramide Synthase Activity","volume":"27","author":"Marshall","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omta.2025.201658_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.276.5311.428","article-title":"Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin","volume":"276","author":"Platt","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.omta.2025.201658_bib7","article-title":"Venglustat in GM2 Gangliosidoses and Related Disorders: Results of the AMETHIST Randomized Controlled and Basket Trials","volume":"28","author":"Tifft","year":"2025","journal-title":"Genet. Med."},{"key":"10.1016\/j.omta.2025.201658_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135889","article-title":"Reducing GBA2 Activity Ameliorates Neuropathology in Niemann-Pick Type C Mice","volume":"10","author":"Marques","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2025.201658_bib9","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1073\/pnas.1400768111","article-title":"Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease","volume":"111","author":"Mistry","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2025.201658_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2019.03.005","article-title":"Cytosolic glucosylceramide regulates endolysosomal function in Niemann-Pick type C disease","volume":"127","author":"Wheeler","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omta.2025.201658_bib11","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1073\/pnas.96.11.6388","article-title":"Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin","volume":"96","author":"Jeyakumar","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2025.201658_bib12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.nbd.2004.04.012","article-title":"Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease","volume":"16","author":"Andersson","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omta.2025.201658_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021758","article-title":"Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease","volume":"6","author":"Ashe","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omta.2025.201658_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2022.107193","article-title":"AZ-3102 significantly increases survival and decreases neuroinflammation in a mouse model of Sandhoff disease","volume":"138","author":"Landskroner","year":"2023","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.omta.2025.201658_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1566523218666180404162622","article-title":"Genetics and Therapies for GM2 Gangliosidosis","volume":"18","author":"Cachon-Gonzalez","year":"2018","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omta.2025.201658_bib16","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11745-008-3268-0","article-title":"Comparative analysis of brain lipids in mice, cats, and humans with Sandhoff disease","volume":"44","author":"Baek","year":"2009","journal-title":"Lipids"},{"key":"10.1016\/j.omta.2025.201658_bib17","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.97.20.10954","article-title":"Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation","volume":"97","author":"Wada","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2025.201658_bib18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13023-018-0876-5","article-title":"Clinical presentation and outcome in infantile Sandhoff disease: a case series of 25 patients from Iranian neurometabolic bioregistry with five novel mutations","volume":"13","author":"Tavasoli","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omta.2025.201658_bib19","first-page":"663","article-title":"The GM1 and GM2 Gangliosidoses: Natural History and Progress toward Therapy","volume":"13","author":"Regier","year":"2016","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.omta.2025.201658_bib20","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1111\/ene.15871","article-title":"Efficacy and safety of miglustat in the treatment of GM2 gangliosidosis: A systematic review","volume":"30","author":"Mansouri","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.omta.2025.201658_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2017.04.011","article-title":"Infantile gangliosidoses: Mapping a timeline of clinical changes","volume":"121","author":"Jarnes Utz","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omta.2025.201658_bib22","author":"Azafaros"},{"key":"10.1016\/j.omta.2025.201658_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omta.2025.201658_bib24","doi-asserted-by":"crossref","first-page":"37929","DOI":"10.1074\/jbc.M104290200","article-title":"Molecular cloning and expression of human bile acid beta-glucosidase","volume":"276","author":"Matern","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omta.2025.201658_bib25","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1172\/JCI29224","article-title":"Mutation of beta-glucosidase 2 causes glycolipid storage disease and impaired male fertility","volume":"116","author":"Yildiz","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omta.2025.201658_bib26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s11064-015-1763-2","article-title":"Current and Novel Aspects on the Non-lysosomal \u03b2-Glucosylceramidase GBA2","volume":"41","author":"Massimo","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.omta.2025.201658_bib27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbr.2008.06.016","article-title":"Early deficits in motor coordination and cognitive dysfunction in a mouse model of the neurodegenerative lysosomal storage disorder, Sandhoff disease","volume":"193","author":"Gulinello","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.omta.2025.201658_bib28","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1093\/hmg\/ddy248","article-title":"Glucosylceramide synthase inhibition with lucerastat lowers globotriaosylceramide and lysosome staining in cultured fibroblasts from Fabry patients with different mutation types","volume":"27","author":"Welford","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omta.2025.201658_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ymgme.2012.01.020","article-title":"Iminosugar-based inhibitors of glucosylceramide synthase prolong survival but paradoxically increase brain glucosylceramide levels in Niemann-Pick C mice","volume":"105","author":"Nietupski","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omta.2025.201658_bib30","article-title":"Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients","volume":"30","author":"Welford","year":"2022","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.omta.2025.201658_bib31","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.3390\/ijms21155368","article-title":"Single Cell Transcriptome Analysis of Niemann-Pick Disease, Type C1 Cerebella","volume":"21","author":"Cougnoux","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omta.2025.201658_bib32","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/hmg\/ddt459","article-title":"Reversibility of neuropathology in Tay\u2013Sachs-related diseases","volume":"23","author":"Cach\u00f3n-Gonz\u00e1lez","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omta.2025.201658_bib33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1873-3468.12104","article-title":"Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases","volume":"590","author":"Ferraz","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omta.2025.201658_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2025.106917","article-title":"Sinbaglustat ameliorates disease pathology in a murine model of GM1 gangliosidosis without affecting CNS ganglioside levels","volume":"210","author":"Wannemacher","year":"2025","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omta.2025.201658_bib35","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1093\/nar\/gks042","article-title":"Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation","volume":"40","author":"McCarthy","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omta.2025.201658_bib36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omta.2025.201658_bib37","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/bioinformatics\/btz700","article-title":"hypeR: an R package for geneset enrichment workflows","volume":"36","author":"Federico","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omta.2025.201658_bib38","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omta.2025.201658_bib39","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omta.2025.201658_bib40","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2017.06.003","article-title":"N-butyldeoxynojirimycin delays motor deficits, cerebellar microgliosis, and Purkinje cell loss in a mouse model of mucolipidosis type IV","volume":"105","author":"Boudewyn","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omta.2025.201658_bib41","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/PL00005603","article-title":"Spontaneous object recognition and object location memory in rats: the effects of lesions in the cingulate cortices, the medial prefrontal cortex, the cingulum bundle and the fornix","volume":"113","author":"Ennaceur","year":"1997","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.omta.2025.201658_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0166-4328(05)80315-8","article-title":"A new one-trial test for neurobiological studies of memory in rats. III. Spatial vs. non-spatial working memory","volume":"51","author":"Ennaceur","year":"1992","journal-title":"Behav. Brain Res."}],"container-title":["Molecular Therapy Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X25000084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3117387X25000084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T20:30:05Z","timestamp":1788553805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3117387X25000084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S3117387X25000084"],"URL":"https:\/\/doi.org\/10.1016\/j.omta.2025.201658","relation":{},"ISSN":["3117-387X"],"issn-type":[{"value":"3117-387X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sinbaglustat is efficacious in GM2 gangliosidosis primarily through inhibition of GBA2 rather than GCS","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omta.2025.201658","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Idorsia Pharmaceuticals Ltd. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201658"}}